摘要
传统的阿片,主要是生物碱,它已经被用于临床痛症一些年了,但是经常会引发神经副作用,包括镇静,头晕,身体依赖性,耐受性,成瘾,恶心,呕吐,便秘和呼吸抑制,这些妨碍了他们的有效使用。来源于食物的阿片肽有像安全和天然改变的明显的优点,可能是因为他们使用动物和植物蛋白生产,同时副作用也就相对较少。这篇综述旨在论述当前关于来源食物的阿片肽并重点关注其生产和鉴定,分离,纯化的方法。为了充分理解阿片肽是作为一种药还是饮食补充食疗验方来实现痛觉管理潜能,强调需要筛选更多的膳食蛋白作为新型阿片肽的来源。
关键词: 阿片,肽,阿片受体,酪啡肽,源外啡肽,发酵。
Current Medicinal Chemistry
Title:Food Proteins as Source of Opioid Peptides-A Review
Volume: 23 Issue: 9
Author(s): Swati Garg, Kulmira Nurgali, Vijay Kumar Mishra
Affiliation:
关键词: 阿片,肽,阿片受体,酪啡肽,源外啡肽,发酵。
摘要: Traditional opioids, mainly alkaloids, have been used in the clinical management of pain for a number of years but are often associated with numerous side-effects including sedation, dizziness, physical dependence, tolerance, addiction, nausea, vomiting, constipation and respiratory depression which prevent their effective use. Opioid peptides derived from food provide significant advantages as safe and natural alternative due to the possibility of their production using animal and plant proteins as well as comparatively less side-effects. This review aims to discuss the current literature on food-derived opioid peptides focusing on their production, methods of detection, isolation and purification. The need for screening more dietary proteins as a source of novel opioid peptides is emphasized in order to fully understand their potential in pain management either as a drug or as part of diet complementing therapeutic prescription.
Export Options
About this article
Cite this article as:
Swati Garg, Kulmira Nurgali, Vijay Kumar Mishra , Food Proteins as Source of Opioid Peptides-A Review, Current Medicinal Chemistry 2016; 23 (9) . https://dx.doi.org/10.2174/0929867323666160219115226
DOI https://dx.doi.org/10.2174/0929867323666160219115226 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Injury-Related Synaptic Plasticity for the Treatment of Chronic Pain
Current Pharmaceutical Design Oncogenomics
Current Drug Metabolism CRH Receptor Signalling: Potential Roles in Pathophysiology
Current Molecular Pharmacology Clinical Importance of Assessment of Type 2 Diabetes Mellitus with Visceral Obesity. A Japanese Perspective
Current Diabetes Reviews Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design De-Novo Ligand Design against Mutated Huntington Gene by Ligand-based Pharmacophore Modeling Approach
Current Computer-Aided Drug Design Granular Non-Fibrillar Aggregates and Toxicity in Alzheimer’s Disease
Current Alzheimer Research Dermatologic Effects of Psychopharmacologic Agents in the Pediatric Population
Current Psychopharmacology Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders
Current Drug Targets - CNS & Neurological Disorders Meet Our Editorial Board Members:
Current Genomics On the Interaction of β-Amyloid Peptides and α7-Nicotinic Acetylcholine Receptors in Alzheimer’s Disease
Current Alzheimer Research Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study
Current Drug Delivery Premature Adrenarche and its Association with Cardiovascular Risk in Females
Current Pharmaceutical Design Review of Pediatric Uveitis
Current Pediatric Reviews Substance P in Rheumatic Diseases
Current Rheumatology Reviews Recent Advances in Psoriasis Therapy: Trends and Future Prospects
Current Drug Targets Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
Current Neuropharmacology The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) Meet Our Editorial Board Member
Current Drug Therapy